down arrow

Kwality Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE552U01010
  • NSEID:
  • BSEID: 539997
INR
817.95
40.95 (5.27%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 2.69 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

805.00830.00

52 Week

441.001,069.95
Valuation
Technical
Day's Volume

CASH

2.69 k (-65.25%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.03%

Held by 0 DIIs

Promoter

54.83%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate 4.96% of over the last 5 years

 
2

Stock is technically in a Mildly Bearish range

3

Despite the size of the company, domestic mutual funds hold only 0% of the company

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 849 Cr (Micro Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.39

stock-summary
Return on Equity

14.07%

stock-summary
Price to Book

3.34

Revenue and Profits (1 Year):
Net Sales:
84 Cr
(Quarterly Results - Dec 2024)
Net Profit:
9 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
2.9%
0%
2.9%
1 Year
73.98%
0%
73.98%
2 Years
163.9%
0%
163.9%
3 Years
50.1%
0%
50.1%
4 Years
1360.62%
0%
1360.62%
5 Years
2538.55%
0%
2538.55%

Latest dividend: 0.6 per share ex-dividend date: Jan-05-2017

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
18.61%
EBIT Growth (5y)
4.96%
EBIT to Interest (avg)
19.12
Debt to EBITDA (avg)
0.86
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.94
Tax Ratio
28.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
16.61%
ROE (avg)
16.77%
Valuation key factors
Factor
Value
P/E Ratio
23
Industry P/E
33
Price to Book Value
3.34
EV to EBIT
15.85
EV to EBITDA
11.99
EV to Capital Employed
2.68
EV to Sales
2.60
PEG Ratio
1.06
Dividend Yield
NA
ROCE (Latest)
16.61%
ROE (Latest)
14.06%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Ramesh Arora (26.01%)

Highest Public shareholder

Deepak Bansal (10.63%)

Individual Investors Holdings

33.25%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 8.08% vs 38.97% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 10.92% vs 8.31% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "84.41",
          "val2": "78.10",
          "chgp": "8.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17.50",
          "val2": "16.69",
          "chgp": "4.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.20",
          "val2": "2.73",
          "chgp": "-19.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8.53",
          "val2": "7.69",
          "chgp": "10.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.73%",
          "val2": "21.37%",
          "chgp": "-0.64%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 24.08% vs 8.79% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 44.34% vs -40.39% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "170.11",
          "val2": "137.10",
          "chgp": "24.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "37.00",
          "val2": "29.00",
          "chgp": "27.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.18",
          "val2": "4.60",
          "chgp": "12.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "16.83",
          "val2": "11.66",
          "chgp": "44.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.75%",
          "val2": "21.15%",
          "chgp": "0.60%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 18.27% vs 18.10% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 31.06% vs -27.42% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "254.52",
          "val2": "215.20",
          "chgp": "18.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "54.50",
          "val2": "45.69",
          "chgp": "19.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.38",
          "val2": "7.33",
          "chgp": "0.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "25.36",
          "val2": "19.35",
          "chgp": "31.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.41%",
          "val2": "21.23%",
          "chgp": "0.18%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 22.36% vs -44.97% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 22.87% vs -83.86% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "307.17",
          "val2": "251.03",
          "chgp": "22.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "66.31",
          "val2": "60.14",
          "chgp": "10.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "10.39",
          "val2": "6.02",
          "chgp": "72.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-7.10",
          "val2": "-16.53",
          "chgp": "57.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "23.80",
          "val2": "19.37",
          "chgp": "22.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.59%",
          "val2": "23.96%",
          "chgp": "-2.37%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
84.41
78.10
8.08%
Operating Profit (PBDIT) excl Other Income
17.50
16.69
4.85%
Interest
2.20
2.73
-19.41%
Exceptional Items
0.00
0.00
Consolidate Net Profit
8.53
7.69
10.92%
Operating Profit Margin (Excl OI)
20.73%
21.37%
-0.64%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 8.08% vs 38.97% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 10.92% vs 8.31% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
170.11
137.10
24.08%
Operating Profit (PBDIT) excl Other Income
37.00
29.00
27.59%
Interest
5.18
4.60
12.61%
Exceptional Items
0.00
0.00
Consolidate Net Profit
16.83
11.66
44.34%
Operating Profit Margin (Excl OI)
21.75%
21.15%
0.60%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 24.08% vs 8.79% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 44.34% vs -40.39% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
254.52
215.20
18.27%
Operating Profit (PBDIT) excl Other Income
54.50
45.69
19.28%
Interest
7.38
7.33
0.68%
Exceptional Items
0.00
0.00
Consolidate Net Profit
25.36
19.35
31.06%
Operating Profit Margin (Excl OI)
21.41%
21.23%
0.18%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 18.27% vs 18.10% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 31.06% vs -27.42% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
307.17
251.03
22.36%
Operating Profit (PBDIT) excl Other Income
66.31
60.14
10.26%
Interest
10.39
6.02
72.59%
Exceptional Items
-7.10
-16.53
57.05%
Consolidate Net Profit
23.80
19.37
22.87%
Operating Profit Margin (Excl OI)
21.59%
23.96%
-2.37%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 22.36% vs -44.97% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 22.87% vs -83.86% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Kwality Pharmaceuticals Ltd stock-summary
stock-summary
Kwality Pharmaceuticals Ltd
Micro Cap
Pharmaceuticals & Drugs
Kwality Pharmaceuticals Limited was Incorporated on May 4th 1983 when its founder Mr. Ramesh Arora was inspired to begin his own venture leaving behind the already flourishing family business of spinning and aromatics. With little background of finished pharmaceuticals and high held spirits and will, he started this business. He received his first drug license in 1981 approved for liquid oral manufacturing. Presently, the Company has 48 different sections available at their production centres.
Company Coordinates stock-summary
Company Details
Village Nagkalan, Majitha Road Amritsar Punjab : 143601
stock-summary
Tel: 91-183-2774321-25
stock-summary
http://www.kwalitypharma.com
stock-summary
cs@kwalitypharma.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."